A. McQuillan

发表

Correlation between the cytotoxicity of melphalan and DNA crosslinks as detected by the ethidium bromide fluorescence assay in the F1 variant of B16 melanoma cells.

L. Panasci, S. Garcia, A. McQuillan, 1988, Biochemical pharmacology.

Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards.

M. Wainberg, J. Hiscott, R. Geleziunas, 1991, Journal of the National Cancer Institute.

A central function for perlecan in skeletal muscle and cardiovascular development

R. Iozzo, A. McQuillan, J. Whitelock, 2008, The Journal of cell biology.

Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.

G. Batist, L. Panasci, J. Bramson, 1995, Mutation research.

Enhanced insulin stimulation of sugar transport and DNA synthesis by glucocorticoids in cultured human skin fibroblasts.

R. Germinario, A. McQuillan, M. Oliveira, 1983, Archives of biochemistry and biophysics.

Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the α2β1-integrin receptor

R. Iozzo, G. Fields, A. McQuillan, 2007 .

Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the alpha2beta1-integrin receptor.

R. Iozzo, G. Fields, A. McQuillan, 2007, Blood.

Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.

A. McQuillan, Z. P. Chen, G. Mohr, 1998, Neurosurgery.

Evidence for nucleotide excision repair as a modifying factor of O6-methylguanine-DNA methyltransferase-mediated innate chloroethylnitrosourea resistance in human tumor cell lines.

J. Remack, T. Brent, A. McQuillan, 1997, Molecular pharmacology.

DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance.

L. Panasci, J. Bramson, A. McQuillan, 1995, Cancer letters.

The cytotoxicity of sarcosinamide chloroethylnitrosourea (SarCNU) and BCNU in primary gliomas and glioma cell lines: analysis of data in reference to theoretical peak plasma concentrations in man

V. Skalski, W. Feindel, L. Panasci, 2004, Cancer Chemotherapy and Pharmacology.

Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU

S. Brem, W. Feindel, L. Panasci, 2004, Cancer Chemotherapy and Pharmacology.

The effect of prolonged incubations and heat denaturation on melphalan-induced DNA cross-links as measured by the ethidium bromide fluorescence assay.

L. Panasci, J. Cohen, A. McQuillan, 1990, Cancer letters.

Biological activity, binding, and metabolic fate of Ac‐[Nle4, D‐Phe7]α‐MSH4–11NH2 with the F1 variant of B16 melanoma cells

M. Kaufman, A. McQuillan, L. C. Panasci, 1987, Journal of cellular physiology.

Evidence for increased αMSH receptor binding in the F1 variant of B16 melanoma cells grown in dialyzed fetal calf serum

A. McQuillan, M. Hutchinson, L. C. Panasci, 1989, Journal of cellular physiology.

Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995.

L. Panasci, A. McQuillan, A. Malapetsa, 1995, Cancer research.

A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity

R. Iozzo, S. Goldoni, D. Keene, 2007, Oncogene.

Glucocorticoid-induced modulation of insulin-stimulated DNA synthesis: differential responsiveness in cell cultures derived from donors of different ages.

R. Germinario, A. McQuillan, 1985, Gerontology.

Brief report Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the (cid:1) 2 (cid:2) 1-integrin receptor

R. Iozzo, G. Fields, A. McQuillan, 2007 .